Compare JLS & MMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | JLS | MMS |
|---|---|---|
| Founded | 2009 | 1975 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Business Services |
| Sector | Finance | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 103.4M | 4.7B |
| IPO Year | N/A | 1997 |
| Metric | JLS | MMS |
|---|---|---|
| Price | $18.34 | $88.18 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $90.00 |
| AVG Volume (30 Days) | 26.6K | ★ 752.7K |
| Earning Date | 01-01-0001 | 02-05-2026 |
| Dividend Yield | ★ 9.33% | 1.36% |
| EPS Growth | N/A | ★ 10.42 |
| EPS | N/A | ★ 5.51 |
| Revenue | N/A | ★ $5,431,276,000.00 |
| Revenue This Year | N/A | $1.71 |
| Revenue Next Year | N/A | $4.98 |
| P/E Ratio | ★ N/A | $15.99 |
| Revenue Growth | N/A | ★ 2.36 |
| 52 Week Low | $15.48 | $63.77 |
| 52 Week High | $17.97 | $92.50 |
| Indicator | JLS | MMS |
|---|---|---|
| Relative Strength Index (RSI) | 38.95 | 59.17 |
| Support Level | $18.15 | $83.72 |
| Resistance Level | $18.51 | $89.41 |
| Average True Range (ATR) | 0.22 | 2.12 |
| MACD | -0.01 | 0.43 |
| Stochastic Oscillator | 25.88 | 82.67 |
Nuveen Mortgage And Income Fund is a diversified, closed-end management investment company. The fund invests at least fifty percent of its Managed Assets in MBS, including residential MBS and commercial MBS, and up to fifty percent in non-mortgage related ABS. Its investment objective to generate high current income through opportunistic investments in securitized credit.
Maximus Inc designs, develops, and delivers programs enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments: U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment, which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.